Assessing pelvic floor function in cancer patients undergoing treatment
PANTHERA-Studie "Pelvic Floor Disorders in Patients Under ANtineoplastic THERApy"
This study looks at how cancer treatments affect bladder, bowel, and sexual function in women with gynecological tumors and breast cancer to help improve their quality of life.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | St. Josefs-Hospital Wiesbaden GmbH Academic / other |
| Locations | 1 site (Wiesbaden) |
| Trial ID | NCT04655066 on ClinicalTrials.gov |
What this trial studies
This observational study evaluates how systemic tumor therapy affects pelvic floor function in patients with gynecological tumors and breast cancer. It utilizes validated questionnaires to gather subjective data on bladder, bowel, and sexual function, aiming to identify potential impairments and influencing factors. The findings could help in developing preventive and therapeutic strategies to improve the quality of life for these patients.
Who should consider this trial
Good fit: Ideal candidates include patients currently undergoing systemic tumor therapy for breast cancer or gynecological carcinoma.
Not a fit: Patients not undergoing systemic tumor therapy or those with other unrelated conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved management and treatment strategies for pelvic floor disorders in cancer patients.
How similar studies have performed: While there is limited data on similar studies, the approach of using validated questionnaires to assess quality of life in cancer patients has shown promise in other contexts.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Breastcancer under tumor therapy * Gynecological carcinoma under tumor therapy Exclusion Criteria: * none
Where this trial is running
Wiesbaden
- St. Josefs-Hospital Wiesbaden GmbH — Wiesbaden, Germany (Recruiting)
Study contacts
- Study coordinator: Boris Gabriel, Prof. Dr. med.
- Email: bgabriel@joho.de
- Phone: +496111771500
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.